WeVote
Log In

Bill

Bill

HD 1502

An Act authorizing a 90-day supply of medically necessary testosterone therapy medication

194th Legislature (2025-2026) Introduced by Jamie Eldridge and 2 co-sponsors

Massachusetts bill permits 90-day testosterone therapy supplies for medically necessary treatment, improving medication access and continuity for patients on hormone therapy.

0
WeVote Research Nonpartisan
Bill Summary · HD 1502

Legislative bill overview

HD 1502 would allow patients to receive a 90-day supply of testosterone therapy medication when medically necessary, rather than being limited to shorter refill periods. The bill aims to improve access and continuity of care for patients requiring ongoing testosterone treatment.

Why is this important

Patients on long-term hormone therapy need reliable, consistent access to medication. Limiting supplies to shorter periods can create gaps in treatment, increase pharmacy visits and costs, and create barriers for patients with transportation or financial constraints. This bill addresses practical access issues for a standard medical treatment.

Potential points of contention

  • Insurance and pharmacy logistics: Questions about whether insurers and pharmacy systems can accommodate 90-day supplies without additional costs or administrative burden
  • Prescription monitoring concerns: Some may raise questions about oversight of controlled substances (though testosterone is not a controlled substance, regulatory caution exists around hormone prescribing)
  • Definition of "medically necessary": Ambiguity about who determines medical necessity and whether this could expand beyond established clinical guidelines
  • Cost implications: Debate over whether longer supplies increase overall medication costs or reduce waste and duplicative visits

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.